Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Medulloblastoma | 21 | 2023 | 678 | 3.200 |
Why?
|
DNA Methylation | 45 | 2024 | 4384 | 1.860 |
Why?
|
Cerebellar Neoplasms | 14 | 2023 | 586 | 1.590 |
Why?
|
Brain Neoplasms | 39 | 2024 | 9003 | 1.130 |
Why?
|
Astrocytoma | 10 | 2023 | 775 | 0.930 |
Why?
|
Isocitrate Dehydrogenase | 12 | 2023 | 929 | 0.700 |
Why?
|
Ependymoma | 7 | 2023 | 320 | 0.680 |
Why?
|
Glioma | 12 | 2024 | 3434 | 0.640 |
Why?
|
Single-Cell Analysis | 8 | 2024 | 2414 | 0.570 |
Why?
|
DNA Copy Number Variations | 12 | 2024 | 2015 | 0.550 |
Why?
|
Glioblastoma | 13 | 2024 | 3481 | 0.540 |
Why?
|
Histones | 12 | 2021 | 2579 | 0.510 |
Why?
|
Gene Expression Regulation, Neoplastic | 16 | 2024 | 8522 | 0.500 |
Why?
|
Central Nervous System Neoplasms | 7 | 2020 | 916 | 0.490 |
Why?
|
Epigenesis, Genetic | 13 | 2024 | 3783 | 0.490 |
Why?
|
Genomics | 9 | 2024 | 5807 | 0.440 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1789 | 0.420 |
Why?
|
Mutation | 33 | 2023 | 30025 | 0.410 |
Why?
|
Chromosomes, Human, Pair 1 | 5 | 2024 | 636 | 0.400 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 4 | 2019 | 491 | 0.380 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2020 | 3778 | 0.360 |
Why?
|
Neuroectodermal Tumors, Primitive | 3 | 2016 | 136 | 0.340 |
Why?
|
Gene Silencing | 3 | 2021 | 1510 | 0.340 |
Why?
|
DEAD-box RNA Helicases | 6 | 2019 | 383 | 0.320 |
Why?
|
Sequence Analysis, DNA | 6 | 2017 | 4718 | 0.320 |
Why?
|
Ribonuclease III | 3 | 2019 | 278 | 0.280 |
Why?
|
Pinealoma | 2 | 2018 | 51 | 0.280 |
Why?
|
Oncogenes | 5 | 2023 | 1223 | 0.270 |
Why?
|
Neoplasms, Neuroepithelial | 2 | 2016 | 42 | 0.260 |
Why?
|
Telomerase | 6 | 2017 | 745 | 0.260 |
Why?
|
Cell Lineage | 5 | 2023 | 2539 | 0.260 |
Why?
|
Neoplasm Proteins | 7 | 2018 | 3611 | 0.260 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 4 | 2023 | 367 | 0.260 |
Why?
|
Rhabdoid Tumor | 3 | 2016 | 210 | 0.260 |
Why?
|
CpG Islands | 8 | 2021 | 1225 | 0.260 |
Why?
|
Sequence Analysis, RNA | 9 | 2020 | 2019 | 0.250 |
Why?
|
Hedgehog Proteins | 4 | 2021 | 768 | 0.250 |
Why?
|
Neurilemmoma | 3 | 2016 | 523 | 0.250 |
Why?
|
Epigenomics | 6 | 2019 | 941 | 0.230 |
Why?
|
Eye Neoplasms | 2 | 2016 | 307 | 0.220 |
Why?
|
Sulfites | 2 | 2021 | 83 | 0.210 |
Why?
|
Metencephalon | 1 | 2022 | 2 | 0.210 |
Why?
|
Gene Expression Profiling | 17 | 2019 | 9415 | 0.210 |
Why?
|
Brain Stem Neoplasms | 2 | 2016 | 190 | 0.210 |
Why?
|
Transcription Factors | 12 | 2017 | 12113 | 0.200 |
Why?
|
Meningioma | 2 | 2024 | 1218 | 0.200 |
Why?
|
Child | 38 | 2023 | 80070 | 0.200 |
Why?
|
Nuclear Proteins | 9 | 2018 | 5789 | 0.200 |
Why?
|
Meningeal Neoplasms | 2 | 2024 | 1248 | 0.200 |
Why?
|
Burkitt Lymphoma | 2 | 2015 | 335 | 0.190 |
Why?
|
Genome | 3 | 2021 | 1739 | 0.190 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2024 | 9265 | 0.190 |
Why?
|
DNA Modification Methylases | 6 | 2018 | 210 | 0.190 |
Why?
|
Neurofibromatoses | 2 | 2016 | 299 | 0.190 |
Why?
|
In Situ Hybridization, Fluorescence | 4 | 2021 | 2510 | 0.180 |
Why?
|
Nucleocytoplasmic Transport Proteins | 1 | 2021 | 73 | 0.180 |
Why?
|
Wnt Proteins | 3 | 2021 | 719 | 0.180 |
Why?
|
Germinal Center | 2 | 2021 | 380 | 0.180 |
Why?
|
Enhancer Elements, Genetic | 3 | 2019 | 1365 | 0.180 |
Why?
|
Neurons | 6 | 2024 | 9436 | 0.180 |
Why?
|
Neoplasms | 4 | 2024 | 22077 | 0.180 |
Why?
|
Child, Preschool | 22 | 2019 | 42204 | 0.180 |
Why?
|
Humans | 91 | 2024 | 760239 | 0.170 |
Why?
|
DNA Repair Enzymes | 6 | 2018 | 346 | 0.170 |
Why?
|
Promoter Regions, Genetic | 7 | 2017 | 5782 | 0.170 |
Why?
|
Genetic Association Studies | 2 | 2019 | 2722 | 0.160 |
Why?
|
Choroid Plexus Neoplasms | 2 | 2016 | 38 | 0.160 |
Why?
|
Cerebellum | 3 | 2023 | 1500 | 0.160 |
Why?
|
Cell Line, Tumor | 12 | 2024 | 16948 | 0.160 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2021 | 3632 | 0.160 |
Why?
|
Mice | 17 | 2024 | 81406 | 0.160 |
Why?
|
MicroRNAs | 4 | 2019 | 3796 | 0.150 |
Why?
|
Pineal Gland | 2 | 2018 | 157 | 0.150 |
Why?
|
Ultraviolet Rays | 1 | 2023 | 1079 | 0.150 |
Why?
|
Genome, Human | 6 | 2018 | 4423 | 0.150 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2023 | 2821 | 0.150 |
Why?
|
Prognosis | 14 | 2024 | 29547 | 0.150 |
Why?
|
Sarcoma | 3 | 2021 | 1791 | 0.150 |
Why?
|
DNA Mutational Analysis | 5 | 2017 | 4108 | 0.150 |
Why?
|
Kruppel-Like Transcription Factors | 3 | 2017 | 502 | 0.150 |
Why?
|
Infant | 17 | 2019 | 36179 | 0.150 |
Why?
|
Gene Duplication | 1 | 2018 | 313 | 0.140 |
Why?
|
Forkhead Transcription Factors | 2 | 2022 | 1611 | 0.140 |
Why?
|
Tumor Microenvironment | 3 | 2019 | 3874 | 0.140 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2020 | 5291 | 0.140 |
Why?
|
Infratentorial Neoplasms | 1 | 2017 | 98 | 0.140 |
Why?
|
DNA Helicases | 4 | 2014 | 851 | 0.140 |
Why?
|
DNA-Binding Proteins | 6 | 2017 | 9590 | 0.140 |
Why?
|
Neuroectodermal Tumors | 1 | 2016 | 22 | 0.130 |
Why?
|
Papilloma, Choroid Plexus | 1 | 2016 | 9 | 0.130 |
Why?
|
Teratoma | 2 | 2016 | 402 | 0.130 |
Why?
|
Ataxia Telangiectasia | 1 | 2017 | 107 | 0.130 |
Why?
|
Muscle Proteins | 2 | 2018 | 1152 | 0.130 |
Why?
|
Animals | 18 | 2024 | 168245 | 0.130 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2023 | 3610 | 0.120 |
Why?
|
Genomic Instability | 2 | 2017 | 709 | 0.120 |
Why?
|
Adolescent | 22 | 2023 | 88173 | 0.120 |
Why?
|
Workflow | 1 | 2020 | 851 | 0.120 |
Why?
|
Nerve Tissue Proteins | 2 | 2021 | 4413 | 0.120 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2019 | 611 | 0.120 |
Why?
|
Gene Regulatory Networks | 2 | 2021 | 1742 | 0.120 |
Why?
|
Genes, p16 | 1 | 2015 | 159 | 0.120 |
Why?
|
Skin Neoplasms | 3 | 2023 | 5815 | 0.120 |
Why?
|
Supratentorial Neoplasms | 1 | 2016 | 159 | 0.120 |
Why?
|
Algorithms | 5 | 2024 | 13990 | 0.120 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2016 | 168 | 0.120 |
Why?
|
Lymphoma, B-Cell | 1 | 2021 | 940 | 0.120 |
Why?
|
Genomic Structural Variation | 1 | 2014 | 63 | 0.120 |
Why?
|
Oligodendroglia | 1 | 2018 | 538 | 0.110 |
Why?
|
Tumor Suppressor Proteins | 7 | 2018 | 2806 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 7 | 2019 | 6472 | 0.110 |
Why?
|
Glutamic Acid | 1 | 2019 | 1174 | 0.110 |
Why?
|
Pyrophosphatases | 1 | 2014 | 142 | 0.110 |
Why?
|
Immunohistochemistry | 5 | 2018 | 11073 | 0.110 |
Why?
|
Gene Deletion | 2 | 2018 | 2667 | 0.110 |
Why?
|
Inhibitor of Differentiation Proteins | 1 | 2012 | 17 | 0.110 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2014 | 201 | 0.110 |
Why?
|
Oligodendroglioma | 1 | 2014 | 279 | 0.110 |
Why?
|
Biological Specimen Banks | 1 | 2018 | 781 | 0.110 |
Why?
|
Chordoma | 1 | 2016 | 346 | 0.110 |
Why?
|
Chromatin | 3 | 2014 | 2951 | 0.110 |
Why?
|
Female | 44 | 2024 | 391766 | 0.100 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2018 | 3592 | 0.100 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2016 | 726 | 0.100 |
Why?
|
Transaminases | 1 | 2013 | 198 | 0.100 |
Why?
|
Receptor, trkB | 1 | 2013 | 124 | 0.100 |
Why?
|
Combined Modality Therapy | 3 | 2019 | 8522 | 0.100 |
Why?
|
Protein Phosphatase 1 | 1 | 2012 | 134 | 0.100 |
Why?
|
Gene Knockout Techniques | 1 | 2015 | 802 | 0.100 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2013 | 256 | 0.100 |
Why?
|
Dendritic Cells | 1 | 2023 | 2726 | 0.100 |
Why?
|
Soft Tissue Neoplasms | 1 | 2021 | 1154 | 0.100 |
Why?
|
Cell Proliferation | 6 | 2022 | 10430 | 0.100 |
Why?
|
Methylation | 4 | 2016 | 1082 | 0.100 |
Why?
|
Neoplasm Metastasis | 2 | 2019 | 4902 | 0.100 |
Why?
|
Male | 39 | 2024 | 359943 | 0.100 |
Why?
|
Adult | 26 | 2024 | 220718 | 0.100 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2014 | 856 | 0.090 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2018 | 2052 | 0.090 |
Why?
|
Disease-Free Survival | 6 | 2017 | 6812 | 0.090 |
Why?
|
Lymphoma, Follicular | 1 | 2015 | 457 | 0.090 |
Why?
|
GTPase-Activating Proteins | 1 | 2014 | 474 | 0.090 |
Why?
|
Survival Analysis | 6 | 2024 | 10074 | 0.090 |
Why?
|
RNA Stability | 1 | 2013 | 331 | 0.090 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2013 | 269 | 0.090 |
Why?
|
Cell Differentiation | 4 | 2021 | 11527 | 0.090 |
Why?
|
Recurrence | 2 | 2019 | 8466 | 0.090 |
Why?
|
Software | 1 | 2024 | 4423 | 0.080 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2014 | 1248 | 0.080 |
Why?
|
Gene Library | 1 | 2012 | 1059 | 0.080 |
Why?
|
Skin | 1 | 2023 | 4474 | 0.080 |
Why?
|
Repressor Proteins | 3 | 2016 | 2979 | 0.080 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2021 | 1857 | 0.080 |
Why?
|
Disease Management | 1 | 2019 | 2500 | 0.080 |
Why?
|
Chromosomes, Human, Pair 19 | 3 | 2014 | 349 | 0.080 |
Why?
|
Base Sequence | 6 | 2019 | 12440 | 0.080 |
Why?
|
Signal Transduction | 8 | 2021 | 23405 | 0.080 |
Why?
|
Protein Biosynthesis | 1 | 2016 | 2114 | 0.080 |
Why?
|
Stress, Physiological | 1 | 2016 | 1400 | 0.080 |
Why?
|
Estrogen Receptor alpha | 1 | 2012 | 581 | 0.080 |
Why?
|
Bone Neoplasms | 1 | 2021 | 2525 | 0.080 |
Why?
|
Binding Sites | 2 | 2014 | 6039 | 0.080 |
Why?
|
Germany | 3 | 2016 | 873 | 0.080 |
Why?
|
Tamoxifen | 1 | 2012 | 964 | 0.080 |
Why?
|
Cluster Analysis | 4 | 2017 | 2712 | 0.070 |
Why?
|
Zebrafish Proteins | 1 | 2014 | 1012 | 0.070 |
Why?
|
Disease Progression | 4 | 2019 | 13483 | 0.070 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 1549 | 0.070 |
Why?
|
Specimen Handling | 1 | 2012 | 703 | 0.070 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2012 | 634 | 0.070 |
Why?
|
Somatic Hypermutation, Immunoglobulin | 2 | 2021 | 101 | 0.070 |
Why?
|
Neoplasm Staging | 2 | 2019 | 11095 | 0.070 |
Why?
|
Young Adult | 14 | 2018 | 59054 | 0.070 |
Why?
|
Molecular Sequence Data | 6 | 2016 | 17617 | 0.070 |
Why?
|
Genes, Immunoglobulin | 2 | 2021 | 285 | 0.070 |
Why?
|
Middle Aged | 21 | 2024 | 220307 | 0.070 |
Why?
|
Neural Stem Cells | 1 | 2014 | 888 | 0.070 |
Why?
|
Zebrafish | 2 | 2016 | 3002 | 0.070 |
Why?
|
Transcription, Genetic | 3 | 2015 | 7595 | 0.070 |
Why?
|
Proteomics | 1 | 2019 | 3818 | 0.070 |
Why?
|
RNA, Messenger | 3 | 2021 | 12787 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 3 | 2018 | 17859 | 0.060 |
Why?
|
Chromosome Deletion | 2 | 2024 | 1387 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 2 | 2016 | 4511 | 0.060 |
Why?
|
RNA-Binding Proteins | 1 | 2014 | 1898 | 0.060 |
Why?
|
Genes, myc | 2 | 2019 | 391 | 0.060 |
Why?
|
Carcinoma | 1 | 2016 | 2328 | 0.060 |
Why?
|
Neurofibromin 1 | 2 | 2016 | 190 | 0.060 |
Why?
|
Principal Component Analysis | 2 | 2017 | 942 | 0.060 |
Why?
|
Bone Marrow Cells | 2 | 2023 | 2415 | 0.060 |
Why?
|
Chromosomes, Human | 2 | 2017 | 442 | 0.050 |
Why?
|
DNA, Neoplasm | 2 | 2019 | 1745 | 0.050 |
Why?
|
Reproducibility of Results | 5 | 2021 | 20076 | 0.050 |
Why?
|
Age Factors | 2 | 2018 | 18369 | 0.050 |
Why?
|
Chromosomes, Human, Pair 9 | 2 | 2014 | 535 | 0.050 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2013 | 3609 | 0.050 |
Why?
|
Computational Biology | 1 | 2013 | 3510 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2022 | 313 | 0.050 |
Why?
|
Oncogene Proteins, Fusion | 3 | 2015 | 1604 | 0.050 |
Why?
|
Gene Dosage | 2 | 2015 | 1219 | 0.050 |
Why?
|
HEK293 Cells | 3 | 2016 | 4273 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2018 | 2898 | 0.040 |
Why?
|
Receptors, Cell Surface | 3 | 2015 | 2819 | 0.040 |
Why?
|
Histone Code | 1 | 2021 | 158 | 0.040 |
Why?
|
Hep G2 Cells | 1 | 2021 | 379 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2019 | 15863 | 0.040 |
Why?
|
Oncogene Proteins | 2 | 2014 | 719 | 0.040 |
Why?
|
Protein Processing, Post-Translational | 2 | 2021 | 1974 | 0.040 |
Why?
|
Clone Cells | 1 | 2023 | 1660 | 0.040 |
Why?
|
Cohort Studies | 6 | 2021 | 41340 | 0.040 |
Why?
|
Mice, Inbred NOD | 2 | 2014 | 1824 | 0.040 |
Why?
|
DNA Topoisomerases, Type I | 1 | 2019 | 106 | 0.040 |
Why?
|
K562 Cells | 1 | 2021 | 643 | 0.040 |
Why?
|
Immunoglobulin Class Switching | 1 | 2021 | 289 | 0.040 |
Why?
|
Antigens, CD34 | 1 | 2021 | 658 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2015 | 2911 | 0.040 |
Why?
|
Aged | 11 | 2024 | 168773 | 0.040 |
Why?
|
Mice, SCID | 2 | 2014 | 2627 | 0.040 |
Why?
|
Chromosome Aberrations | 2 | 2015 | 1771 | 0.040 |
Why?
|
Translocation, Genetic | 2 | 2015 | 1387 | 0.040 |
Why?
|
Pons | 1 | 2019 | 239 | 0.040 |
Why?
|
Organ Specificity | 1 | 2023 | 1956 | 0.040 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2020 | 553 | 0.040 |
Why?
|
Orphan Nuclear Receptors | 1 | 2018 | 63 | 0.040 |
Why?
|
beta Catenin | 2 | 2014 | 1044 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2018 | 66 | 0.040 |
Why?
|
Cell Death | 1 | 2023 | 1665 | 0.040 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2019 | 427 | 0.040 |
Why?
|
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2017 | 44 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13618 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2017 | 2455 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2013 | 7850 | 0.030 |
Why?
|
Apoptosis | 1 | 2012 | 9469 | 0.030 |
Why?
|
Austria | 1 | 2016 | 206 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2022 | 1753 | 0.030 |
Why?
|
INDEL Mutation | 1 | 2017 | 267 | 0.030 |
Why?
|
Melanoma | 1 | 2014 | 5704 | 0.030 |
Why?
|
Switzerland | 1 | 2016 | 323 | 0.030 |
Why?
|
Neurofibromin 2 | 1 | 2017 | 270 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2015 | 18218 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2019 | 64583 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2018 | 641 | 0.030 |
Why?
|
B-Lymphocytes | 2 | 2021 | 4747 | 0.030 |
Why?
|
Epistasis, Genetic | 1 | 2017 | 351 | 0.030 |
Why?
|
Lysine | 1 | 2019 | 993 | 0.030 |
Why?
|
HeLa Cells | 1 | 2021 | 3095 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 696 | 0.030 |
Why?
|
Cell Cycle | 2 | 2013 | 2929 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 2012 | 20969 | 0.030 |
Why?
|
Aged, 80 and over | 5 | 2018 | 58838 | 0.030 |
Why?
|
Probability | 1 | 2020 | 2474 | 0.030 |
Why?
|
Synaptophysin | 1 | 2014 | 138 | 0.030 |
Why?
|
RNA, Neoplasm | 1 | 2017 | 749 | 0.030 |
Why?
|
Genes, Neoplasm | 1 | 2016 | 370 | 0.030 |
Why?
|
Cranial Irradiation | 1 | 2016 | 390 | 0.030 |
Why?
|
Rhombencephalon | 1 | 2014 | 81 | 0.030 |
Why?
|
Sequence Analysis | 1 | 2014 | 240 | 0.030 |
Why?
|
E2F1 Transcription Factor | 1 | 2014 | 178 | 0.030 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2018 | 856 | 0.030 |
Why?
|
Cytodiagnosis | 1 | 2017 | 447 | 0.030 |
Why?
|
Liposarcoma, Myxoid | 1 | 2013 | 60 | 0.030 |
Why?
|
Cell Line | 2 | 2021 | 15602 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 2017 | 733 | 0.030 |
Why?
|
Chromosome Breakpoints | 1 | 2013 | 93 | 0.030 |
Why?
|
Homozygote | 1 | 2018 | 1793 | 0.030 |
Why?
|
Genes, Developmental | 1 | 2013 | 38 | 0.030 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2014 | 346 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2012 | 3429 | 0.030 |
Why?
|
Dacarbazine | 1 | 2016 | 559 | 0.030 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 381 | 0.030 |
Why?
|
Chromosome Disorders | 1 | 2016 | 499 | 0.030 |
Why?
|
RNA-Induced Silencing Complex | 1 | 2013 | 56 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2018 | 80414 | 0.030 |
Why?
|
Transcription Initiation Site | 1 | 2013 | 188 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2014 | 671 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2018 | 1343 | 0.030 |
Why?
|
Survival Rate | 2 | 2017 | 12697 | 0.030 |
Why?
|
Amino Acid Sequence | 2 | 2016 | 13442 | 0.030 |
Why?
|
Gene Fusion | 1 | 2015 | 354 | 0.030 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2016 | 617 | 0.030 |
Why?
|
Ontario | 1 | 2013 | 399 | 0.020 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2013 | 373 | 0.020 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2012 | 286 | 0.020 |
Why?
|
Polyploidy | 1 | 2012 | 119 | 0.020 |
Why?
|
Metabolism | 1 | 2013 | 193 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2016 | 1527 | 0.020 |
Why?
|
Phenotype | 3 | 2014 | 16588 | 0.020 |
Why?
|
Co-Repressor Proteins | 1 | 2012 | 191 | 0.020 |
Why?
|
Luciferases | 1 | 2012 | 714 | 0.020 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2012 | 452 | 0.020 |
Why?
|
Genes, Dominant | 1 | 2013 | 862 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2018 | 1624 | 0.020 |
Why?
|
Neurofibromatosis 2 | 1 | 2014 | 385 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2850 | 0.020 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2012 | 329 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2017 | 1264 | 0.020 |
Why?
|
Cilia | 1 | 2014 | 494 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 2014 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2015 | 989 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2015 | 1228 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 4570 | 0.020 |
Why?
|
T-Box Domain Proteins | 1 | 2012 | 468 | 0.020 |
Why?
|
Histone Demethylases | 1 | 2012 | 320 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2016 | 12967 | 0.020 |
Why?
|
Prospective Studies | 3 | 2022 | 54304 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2015 | 1114 | 0.020 |
Why?
|
Radiotherapy | 1 | 2016 | 1498 | 0.020 |
Why?
|
Age Distribution | 1 | 2015 | 2878 | 0.020 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2013 | 682 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 2017 | 1347 | 0.020 |
Why?
|
World Health Organization | 1 | 2015 | 1315 | 0.020 |
Why?
|
Biphenyl Compounds | 1 | 2014 | 1003 | 0.020 |
Why?
|
RNA | 1 | 2019 | 2720 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 1404 | 0.020 |
Why?
|
Bone Marrow | 1 | 2019 | 2907 | 0.020 |
Why?
|
Internet | 1 | 2021 | 3090 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2013 | 1171 | 0.020 |
Why?
|
Microglia | 1 | 2017 | 1357 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2011 | 1992 | 0.020 |
Why?
|
DNA Repair | 1 | 2017 | 2045 | 0.020 |
Why?
|
Fibroblast Growth Factors | 1 | 2013 | 867 | 0.020 |
Why?
|
Molecular Chaperones | 1 | 2012 | 755 | 0.020 |
Why?
|
Mice, Nude | 1 | 2013 | 3603 | 0.020 |
Why?
|
Embryonic Stem Cells | 1 | 2014 | 1262 | 0.020 |
Why?
|
Receptors, Progesterone | 1 | 2011 | 1126 | 0.020 |
Why?
|
Trans-Activators | 1 | 2016 | 2859 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2013 | 1485 | 0.020 |
Why?
|
Glycoproteins | 1 | 2014 | 2207 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2015 | 2443 | 0.020 |
Why?
|
Age of Onset | 1 | 2013 | 3301 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6765 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2804 | 0.020 |
Why?
|
Genome-Wide Association Study | 2 | 2017 | 12665 | 0.020 |
Why?
|
Telomere | 1 | 2012 | 929 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 14661 | 0.020 |
Why?
|
Protein Conformation | 1 | 2013 | 3969 | 0.020 |
Why?
|
Blotting, Western | 1 | 2012 | 5034 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2012 | 6129 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2014 | 2859 | 0.010 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2012 | 1517 | 0.010 |
Why?
|
Genotype | 1 | 2019 | 12971 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2012 | 4631 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2013 | 2571 | 0.010 |
Why?
|
Genetic Loci | 1 | 2013 | 2629 | 0.010 |
Why?
|
RNA Interference | 1 | 2012 | 2834 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2017 | 4940 | 0.010 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2011 | 1085 | 0.010 |
Why?
|
Pediatrics | 1 | 2018 | 3593 | 0.010 |
Why?
|
Antigens, CD | 1 | 2014 | 4000 | 0.010 |
Why?
|
Gene Expression | 1 | 2016 | 7586 | 0.010 |
Why?
|
Models, Molecular | 1 | 2013 | 5424 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2011 | 3586 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2011 | 2201 | 0.010 |
Why?
|
Pyridines | 1 | 2014 | 2868 | 0.010 |
Why?
|
Macrophages | 1 | 2017 | 5763 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9591 | 0.010 |
Why?
|
Peptides | 1 | 2014 | 4338 | 0.010 |
Why?
|
Protein Binding | 1 | 2013 | 9339 | 0.010 |
Why?
|
Brain | 2 | 2019 | 27049 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2011 | 2553 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12050 | 0.010 |
Why?
|
Risk Factors | 2 | 2016 | 73999 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2014 | 14400 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2013 | 12420 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2016 | 22079 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2013 | 18960 | 0.010 |
Why?
|
Models, Biological | 1 | 2013 | 9461 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 11729 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11906 | 0.010 |
Why?
|
Risk Assessment | 1 | 2016 | 23942 | 0.010 |
Why?
|
Aging | 1 | 2012 | 8686 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39067 | 0.010 |
Why?
|
Time Factors | 1 | 2013 | 39928 | 0.010 |
Why?
|